Trial
NCT00622401
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
Dana-Farber Cancer Institute; Brigham and Women's Hospital; Harvard Medical School (HMS and HSDM); United States Department of Defense; National Cancer Institute (NCI)
Condition
Breast Cancer
Intervention
Dendritic Cell/Tumor Fusion Vaccine
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-14